Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 481415
                    [Title] => Suicidality overlooked in diagnosis of depression
                    [Summary] => 
In a randomized trial involving actors portraying patients with major depression, internists and family physicians usually failed to ask these patients about suicidality, even when they correctly made the depression diagnosis.
                    [DatePublished] => 2009-06-28 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 62817
                    [Title] => FDA calls for stronger antidepressant warning
                    [Summary] => 
            
                    [DatePublished] => 2008-05-18 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 394542
                    [Title] => FDA scrutinizes antidepressants,risk of suicidality
                    [Summary] => 






Warning may be applied to young adults. Concerns about the risk of suicidality in patients on antidepressant therapy have deepened as a result of a Food and Drug Administration advisory panel’s recommendation to expand a black box warning to include young adults. The proposal also sparked concern, expressed by some of the panelists, that extension of the warning might discourage appropriate antidepressant prescribing.
                    [DatePublished] => 2007-04-15 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

SUICIDALITY

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 481415
                    [Title] => Suicidality overlooked in diagnosis of depression
                    [Summary] => 
In a randomized trial involving actors portraying patients with major depression, internists and family physicians usually failed to ask these patients about suicidality, even when they correctly made the depression diagnosis.
                    [DatePublished] => 2009-06-28 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 62817
                    [Title] => FDA calls for stronger antidepressant warning
                    [Summary] => 
            
                    [DatePublished] => 2008-05-18 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 394542
                    [Title] => FDA scrutinizes antidepressants,risk of suicidality
                    [Summary] => 






Warning may be applied to young adults. Concerns about the risk of suicidality in patients on antidepressant therapy have deepened as a result of a Food and Drug Administration advisory panel’s recommendation to expand a black box warning to include young adults. The proposal also sparked concern, expressed by some of the panelists, that extension of the warning might discourage appropriate antidepressant prescribing.
                    [DatePublished] => 2007-04-15 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Suicidality overlooked in diagnosis of depression

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | June 28, 2009 - 12:00am

In a randomized trial involving actors portraying patients with major depression, internists and family physicians usually failed to ask these patients about suicidality, even when they correctly made the depression...

Opinion

FDA calls for stronger antidepressant warning

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | May 18, 2008 - 12:00am

Opinion

FDA scrutinizes antidepressants,risk of suicidality

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | April 15, 2007 - 12:00am

Warning may be applied to young adults. Concerns about the risk of suicidality in patients on antidepressant therapy have deepened as a result of a Food and Drug Administration advisory panel’s...

Opinion